Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size.

S W Halpern, G Ellrodt, B N Singh, W J Mandel

The efficacy of intravenous procainamide, infused at 30 mg/min to a maximum dose of 20 mg/kg, in converting atrial fibrillation was evaluated under electrocardiographic and blood pressure control in 21 patients. Nine patients had atherosclerotic heart disease, seven had valvular lesions, five had hypertension, and six had no apparent heart disease. Nine patients (converters), who reverted to sinus rhythm at a mean dose of procainamide of 13.3 +/- 3.6 mg/kg (mean plasma concentration, 7.4 +/- 3.9 micrograms/ml) had normal echocardiographic left atrial diameters. All but one of the remainder, the 12 non-converters, who received a mean drug dose of 13.1 +/- 3.5 mg/kg (mean plasma concentration 13.9 +/- 7.6 micrograms/ml), had atrial diameters exceeding 4.0 cm. QRS and QTc intervals were not altered significantly in converters, but were prolonged significantly in non-converters. No serious side effects from the infusion were encountered. Intravenous procainamide infusion appears to be a safe and rapidly effective method of converting recent-onset atrial fibrillation to sinus rhythm in patients with normal left atrial dimensions.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Roy, D., Rowe, B. H., Stiell, I. G., Coutu, B., Ip, J. H., Phaneuf, D., Lee, J., Vidaillet, H., Dickinson, G., Grant, S., Ezrin, A. M., Beatch, G. N., for the CRAFT Investigators, (2004). A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation. J Am Coll Cardiol 44: 2355-2361 [Abstract] [Full Text]  
• Bianconi, L, Castro, A, Dinelli, M, Alboni, P, Pappalardo, A, Richiardi, E, Santini, M (2000). Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study. Eur Heart J 21: 1265-1273 [Abstract]  
• Murray, K. T. (1998). Ibutilide. Circulation 97: 493-497 [Full Text]  
• Stambler, B. S., Wood, M. A., Ellenbogen, K. A. (1997). Antiarrhythmic Actions of Intravenous Ibutilide Compared With Procainamide During Human Atrial Flutter and Fibrillation : Electrophysiological Determinants of Enhanced Conversion Efficacy. Circulation 96: 4298-4306 [Abstract] [Full Text]  
• Cheitlin, M. D., Alpert, J. S., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davidson, T. W., Davis, J. L., Douglas, P. S., Gillam, L. D., Lewis, R. P., Pearlman, A. S., Philbrick, J. T., Shah, P. M., Williams, R. G., Ritchie, J. L., Cheitlin, M. D., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Gibbons, R. J., Lewis, R. P., O'Rourke, R. A., Ryan, T. J. (1997). ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography. Circulation 95: 1686-1744 [Full Text]  
• Serdar Fak, A., Tezcan, H., Caymaz, O., Tokay, S., Oktay, S., Oktay, A. (1997). Intravenous Propafenone for Conversion of Atrial Fibrillation or Flutter to Sinus Rhythm: A Randomized, Placebo-controlled, Crossover Study. J CARDIOVASC PHARMACOL THER 2: 251-257 [Abstract]  
• Stambler, B. S., Wood, M. A., Ellenbogen, K. A., Perry, K. T., Wakefield, L. K., VanderLugt, J. T. (1996). Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation. Circulation 94: 1613-1621 [Abstract] [Full Text]  
• Blevins, R. D., Kerin, N. Z., Benaderet, D., Frumin, H., Faitel, K., Jarandilla, R., Rubenfire, M. (1987). Amiodarone in the Management of Refractory Atrial Fibrillation. Arch Intern Med 147: 1401-1404 [Abstract]